首页 | 本学科首页   官方微博 | 高级检索  
     

异基因骨髓联合外周干细胞移植术治疗白血病12例
引用本文:李敬东,韩效林,李志英. 异基因骨髓联合外周干细胞移植术治疗白血病12例[J]. 医学信息, 2008, 21(7)
作者姓名:李敬东  韩效林  李志英
作者单位:新乡医学院第一附属医院血液科,河南卫辉453100
摘    要:目的探讨异基因骨髓联合外周干细胞移植术在白血病治疗中的应用,评价其疗效和安全性。方法12例白血病患者接受异基因骨髓联合外周干细胞移植,其中急性白血病8例,慢性白血病4例,供者均为同胞HIA配型全相合,预处理方案采用“改良BU/CY2”,分两天采集外周干细胞及骨髓不做任何处理输注。移植后观察预处理毒副作用、移植相关并发症、植入情况、生存情况,并与同期白血病患者(单用化疗治疗)生存情况对比。最长随访时间25月。结果12例患者中1例早期死于肝静脉阻塞综合征,11例植入顺利并存活至今,生存率明显高于化疗组。1例发生Ⅰ度aGVHD,2例发生局限性cGVHD,发生时间分别为+150d、+130d发生肝静脉阻塞综合征1例,发生时间为+10d。毒副作用主要为恶心、呕吐、肝肾功能损伤。结论异基因骨髓联合外周干细胞移植术安全有效、并发症少,值得推广。

关 键 词:造血干细胞移植  白血病  治疗

12 patients with leukemia treated by allo-hematopoietic stem cell transplantation mixed with marrow and PBSC
LI Jing-dong,HAN Xiao-lin,LI Zhi-ying. 12 patients with leukemia treated by allo-hematopoietic stem cell transplantation mixed with marrow and PBSC[J]. Medical Information, 2008, 21(7)
Authors:LI Jing-dong  HAN Xiao-lin  LI Zhi-ying
Affiliation:LI Jing-dong,HAN Xiao-lin,LI Zhi-ying(Department of Blood,the First Affiliated Hospital of Xinxiang Medical University,Weihui 453100,Henan Province,China)
Abstract:Objective To evaluate the outcome of 12 patients with leukemia undergoing allo-hematopoietic stem cell transplantation.Methods Twelve patients with leukemia,including 8 acute myeloid leukemia(AML,CR1),4 chronic myeloid leukemia(CML,CP)received allo-geneic hematopoietic stem cells from HLA-identical siblings,BU-CY2 was used as conditioning regimen,marrow mixed peripheral blood stem cell was infused in 2 days,without any arranged.Research the side-effect and complication of conditioning regimen,grafting,survi...
Keywords:allo-hematopoietic stem cell transplantation  leukemia  treatment  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号